Fig. 5.

Risk score analysis of the prognostic signature based on the GSE70769 and entire TCGA cohorts. A Kaplan–Meier survival curve analysis of BCRs between the high- and low-risk groups in the GSE70769 cohort. B 1-year, 3-year, and 5-year ROC curves of PCa patients in the GSE70769 cohort. C Risk score and survival status of each PCa patient in the GSE70769 cohort. D Heatmap of prognostic MTGs expression based on the risk score and clinical characteristics in the GSE70769 cohort. E Kaplan–Meier survival curve analysis of BCRs between the high- and low-risk groups in the entire TCGA cohort. F 1-year, 3-year, and 5-year ROC curves of PCa patients in the entire TCGA cohort. G Risk score and survival status of each PCa patient in the entire TCGA cohort. H Heatmap of prognostic MTGs expression based on the risk score and clinical characteristics in the entire TCGA cohort